On July 5th, Glon Hui | Sanofi (SNY.US) rose by more than 1.2%, reaching $49.45. On the news front, French state-owned investment company Bpifrance is considering joining the race to purchase Sanofi's consumer health business. Sanofi is negotiating the spin-off of its consumer health product branch and is considering options including overall sales. Bain Capital and Cinven, as well as private equity funds interested in acquiring related assets, and the acquisition fund PAI Partners, are interested in participating in the bidding. The market estimates that the transaction value of the sale action may reach as high as $20 billion.
美股异动丨赛诺菲涨超1.2% 法国政府投资公司据称考虑竞购其健护业务
US stocks unusual | Sanofi rose more than 1.2%, and the French government investment company is reportedly considering bidding for its health protection business.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.